
|Articles|January 30, 2023
POLL: Which Adalimumab Biosimilar Will be Available First in 2023?
Author(s)Dermatology Times Staff
Click here to answer this week's poll.
Advertisement
Which Adalimumab Biosimilar Will be Available First in 2023?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The Emerging Role of Oral Peptide Therapeutics in Dermatology
2
Novel Botanical Moisturizer Demonstrates Superior Efficacy Over Metronidazole in Phase 2 Rosacea Trial
3
Suneel Chilukuri, MD on the Crucial Role of Barrier Repair and Tailored BPO Therapy
4
Rese-cel Data Support Registrational Strategy Across Dermatomyositis, Systemic Sclerosis, Lupus
5














